An Open Randomised Trial of Zoladex versus CMF as Adjuvant Therapy in the Management of Node Positive Stage II Breast Cancer in Pre/Peri-Menopausal Women Aged 50 Years or Less

Mise à jour : Il y a 4 ans
Référence : ISRCTN15682734